CONMED Corp Files 8-K
Ticker: CNMD · Form: 8-K · Filed: Jan 13, 2025 · CIK: 816956
Sentiment: neutral
Topics: sec-filing, 8-k, reporting
Related Tickers: CNMD
TL;DR
CONMED filed a routine 8-K, no major news.
AI Summary
CONMED Corporation filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates CONMED Corporation is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting purposes and does not disclose any new material risks or events.
Key Players & Entities
- CONMED Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 11311 Concept Blvd Largo, FL 33773 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits, as per SEC requirements.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is January 13, 2025.
What is CONMED Corporation's state of incorporation?
CONMED Corporation's state of incorporation is Delaware.
What is the address of CONMED Corporation's principal executive offices?
The address of CONMED Corporation's principal executive offices is 11311 Concept Blvd, Largo, FL 33773.
Does this filing disclose any specific financial results or material events?
This filing does not disclose any specific financial results or material events beyond the standard reporting categories of Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-13 09:00:18
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by ch
Filing Documents
- d906274d8k.htm (8-K) — 25KB
- d906274dex991.htm (EX-99.1) — 16KB
- g906274dsp004.jpg (GRAPHIC) — 83KB
- g906274dsp005.jpg (GRAPHIC) — 255KB
- g906274dsp006.jpg (GRAPHIC) — 143KB
- g906274dsp007.jpg (GRAPHIC) — 178KB
- g906274dsp008.jpg (GRAPHIC) — 145KB
- g906274dsp009.jpg (GRAPHIC) — 144KB
- g906274dsp010.jpg (GRAPHIC) — 160KB
- g906274dsp011.jpg (GRAPHIC) — 179KB
- g906274dsp012.jpg (GRAPHIC) — 116KB
- g906274dsp013.jpg (GRAPHIC) — 158KB
- g906274dsp014.jpg (GRAPHIC) — 213KB
- g906274dsp015.jpg (GRAPHIC) — 139KB
- 0001193125-25-005046.txt ( ) — 2794KB
- cnmd-20250113.xsd (EX-101.SCH) — 3KB
- cnmd-20250113_lab.xml (EX-101.LAB) — 17KB
- cnmd-20250113_pre.xml (EX-101.PRE) — 11KB
- d906274d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits The following exhibit is included as part of this Current Report on Form 8-K: Number Description of Exhibits 99.1 CONMED Corporation Investor Presentation dated January 13, 2025. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President-Chief Financial Officer